Patents by Inventor Jesper Neergaard

Jesper Neergaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12245627
    Abstract: An oral pouched product is disclosed, the oral pouched product includes a saliva permeable pouch, a non-tobacco pouch composition, the pouch composition includes heat-treated fibers, nicotine in an amount of 0.1-5.0% by weight of the pouch compositions, water in an amount 15-65% by weight of the pouch composition, at least one sugar alcohol, and less than 0.5% preservative by weight of the pouch composition. Also, a method for manufacturing an oral pouched product is disclosed.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: March 11, 2025
    Assignee: PHILIP MORRIS PRODUCTS S.A.
    Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
  • Patent number: 11930838
    Abstract: An oral pouched product is disclosed, the pouched product comprising a saliva permeable pouch and a pouch composition, the pouch composition comprising a powdered composition, water, and a liquid flavor composition, wherein the liquid flavor composition is added to the powdered composition after the water. A further oral pouched product and a method of manufacturing an oral pouched product is disclosed.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: March 19, 2024
    Assignee: PHILIP MORRIS PRODUCTS S.A.
    Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
  • Patent number: 11805802
    Abstract: A nicotine pouch composition is disclosed, the pouch composition includes at least one sugar alcohol, at least one water-insoluble fiber, water in an amount of 8-65% by weight of the composition, and nicotine. Also, an oral pouched nicotine product and a method for manufacturing an oral pouched product is disclosed.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: November 7, 2023
    Assignee: PHILIP MORRIS PRODUCTS S.A.
    Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
  • Patent number: 11730757
    Abstract: The invention relates to a solid pharmaceutical tablet for oral delivery, the tablet comprising calcium carbonate in an amount of more than 30% by weight of the tablet and organic water-insoluble components in an amount of more than 20% by weight of the tablet, wherein the tablet is designed to be masticated into a coherent residual containing the organic water-insoluble components, and wherein the tablet is adapted to release more than 80% of the calcium carbonate within 5 minutes of mastication.
    Type: Grant
    Filed: March 21, 2019
    Date of Patent: August 22, 2023
    Assignee: Fertin Pharma A/S
    Inventor: Jesper Neergaard
  • Patent number: 11723918
    Abstract: The invention relates to a solid pharmaceutical tablet for oral delivery, the tablet comprising calcium carbonate in an amount of more than 30% by weight of the tablet and organic water-insoluble components in an amount of more than 20% by weight of the tablet, wherein the tablet is designed to be masticated into a coherent residual containing the organic water-insoluble components, and wherein the tablet is adapted to release more than 80% of the calcium carbonate within 5 minutes of mastication.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: August 15, 2023
    Assignee: FERTIN PHARMA A/S
    Inventor: Jesper Neergaard
  • Publication number: 20220322727
    Abstract: An oral pouched product is disclosed, the oral pouched product includes a saliva permeable pouch, a non-tobacco pouch composition, the pouch composition includes heat-treated fibers, nicotine in an amount of 0.1-5.0% by weight of the pouch compositions, water in an amount 15-65% by weight of the pouch composition, at least one sugar alcohol, and less than 0.5% preservative by weight of the pouch composition. Also, a method for manufacturing an oral pouched product is disclosed.
    Type: Application
    Filed: June 23, 2022
    Publication date: October 13, 2022
    Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
  • Patent number: 11399562
    Abstract: An oral pouched product is disclosed, the oral pouched product includes a saliva permeable pouch, a pouch composition, the pouch composition includes heat-treated fibers, nicotine, water in an amount of less than 65% by weight of the pouch composition, and at least one sugar alcohol. Also, a method for manufacturing an oral pouched product is disclosed.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: August 2, 2022
    Assignee: NCP NextGen A/S
    Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
  • Patent number: 11311623
    Abstract: The present invention relates to a nicotine delivery product comprising, or even consisting essentially of, a population of nicotine-loaded cation exchange resin particles, said population comprises at least 50% (w/w) particles having a size in the range of 90-300 micron which provides an improved nicotine stability to oral dosage forms comprising the nicotine delivery product. The invention furthermore relates to methods of producing the nicotine delivery product and the oral dosage forms and to the use of the nicotine delivery product.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: April 26, 2022
    Assignee: Fertin Pharma A/S
    Inventors: Jesper Thorsen, Bjarne Vestbö, Birgitte Kringelum Breindal, Jesper Neergaard
  • Publication number: 20220087929
    Abstract: An oral pouched product is disclosed, the oral pouched product includes a saliva permeable pouch, a pouch composition, the pouch composition includes heat-treated fibers, nicotine, water in an amount of less than 65% by weight of the pouch composition, and at least one sugar alcohol. Also, a method for manufacturing an oral pouched product is disclosed.
    Type: Application
    Filed: June 5, 2020
    Publication date: March 24, 2022
    Applicant: NCP NextGen A/S
    Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
  • Publication number: 20220039455
    Abstract: An oral pouched product is disclosed, the pouched product comprising a saliva permeable pouch and a pouch composition, the pouch composition comprising a powdered composition, water, and a liquid flavor composition, wherein the liquid flavor composition is added to the powdered composition after the water. A further oral pouched product and a method of manufacturing an oral pouched product is disclosed.
    Type: Application
    Filed: June 5, 2020
    Publication date: February 10, 2022
    Applicant: NCP NextGen A/S
    Inventors: My Ly Lao Stahl, Heidi Ziegler Bruun, Bruno Provstgaard Nielsen, Jesper Neergaard, Bine Hare Jakobsen
  • Publication number: 20210307375
    Abstract: A nicotine pouch composition is disclosed, the pouch composition includes at least one sugar alcohol, at least one water-insoluble fiber, water in an amount of 8-65% by weight of the composition, and nicotine. Also, an oral pouched nicotine product and a method for manufacturing an oral pouched product is disclosed.
    Type: Application
    Filed: June 5, 2020
    Publication date: October 7, 2021
    Inventors: My Ly Lao STAHL, Heidi Ziegler BRUUN, Bruno Provstgaard NIELSEN, Jesper NEERGAARD, Bine Hare JAKOBSEN
  • Publication number: 20210205355
    Abstract: The invention relates to a solid pharmaceutical tablet for oral delivery, the tablet comprising calcium carbonate in an amount of more than 30% by weight of the tablet and organic water-insoluble components in an amount of more than 20% by weight of the tablet, wherein the tablet is designed to be masticated into a coherent residual containing the organic water-insoluble components, and wherein the tablet is adapted to release more than 80% of the calcium carbonate within 5 minutes of mastication.
    Type: Application
    Filed: March 19, 2021
    Publication date: July 8, 2021
    Inventor: Jesper NEERGAARD
  • Patent number: 10980831
    Abstract: The invention relates to a solid pharmaceutical tablet for oral delivery, the tablet comprising calcium carbonate in an amount of more than 30% by weight of the tablet and organic water-insoluble components in an amount of more than 20% by weight of the tablet, wherein the tablet is designed to be masticated into a coherent residual containing the organic water-insoluble components, and wherein the tablet is adapted to release more than 80% of the calcium carbonate within 5 minutes of mastication.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: April 20, 2021
    Assignee: FERTIN PHARMA A/S
    Inventor: Jesper Neergaard
  • Patent number: 10945949
    Abstract: A medical chewing gum including gum base polymers and one or more cannabinoids as an active pharmaceutical ingredient, the gum base polymers including polyvinyl acetate and vinyl laurate-vinyl acetate copolymer in an amount of more than 90% by weight of the gum base polymers, wherein the gum base polymers include 20-95% by weight of polyvinyl acetate and 5-80% by weight of vinyl laurate-vinyl acetate copolymer.
    Type: Grant
    Filed: October 7, 2015
    Date of Patent: March 16, 2021
    Inventors: Jesper Neergaard, Anayo Ogbonna
  • Publication number: 20210023128
    Abstract: The invention relates to a solid pharmaceutical tablet for oral delivery, the tablet comprising calcium carbonate in an amount of more than 30% by weight of the tablet and organic water-insoluble components in an amount of more than 20% by weight of the tablet, wherein the tablet is designed to be masticated into a coherent residual containing the organic water-insoluble components, and wherein the tablet is adapted to release more than 80% of the calcium carbonate within 5 minutes of mastication.
    Type: Application
    Filed: March 21, 2019
    Publication date: January 28, 2021
    Applicant: Fertin Pharma A/S
    Inventor: Jesper Neergaard
  • Patent number: 10485247
    Abstract: A nicotine chewing gum is disclosed, the nicotine chewing gum having gum base polymers, nicotine, and microcrystalline cellulose as a carrier for the nicotine, the gum base polymers include polyvinyl acetate and vinyl laurate-vinyl acetate copolymer in an amount of more than 90% by weight of the gum base polymers, and the gum base polymers include 20-95% by weight of polyvinyl acetate and 5-80% by weight of vinyl laurate-vinyl acetate copolymer. Also, a method for producing a nicotine chewing gum is disclosed.
    Type: Grant
    Filed: October 7, 2015
    Date of Patent: November 26, 2019
    Assignee: Fertin Pharma A/S
    Inventor: Jesper Neergaard
  • Patent number: 10426726
    Abstract: The invention relates to a medical chewing gum comprising gum base polymers and an active pharmaceutical ingredient, the gum base polymers comprising polyvinyl acetate and vinyl laurate-vinyl acetate copolymer in an amount of more than 90% by weight, wherein the gum base polymers include 20-95% by weight of polyvinyl acetate and -80% by weight of vinyl laurate-vinyl acetate copolymer, and wherein the chewing gum contains no polyterpene resins and no resins based on gum rosin, wood rosin or tall oil resin.
    Type: Grant
    Filed: April 8, 2015
    Date of Patent: October 1, 2019
    Assignee: FERTIN PHARMA A/S
    Inventor: Jesper Neergaard
  • Publication number: 20190290684
    Abstract: The invention relates to a solid pharmaceutical tablet for oral delivery, the tablet comprising calcium carbonate in an amount of more than 30% by weight of the tablet and organic water-insoluble components in an amount of more than 20% by weight of the tablet, wherein the tablet is designed to be masticated into a coherent residual containing the organic water-insoluble components, and wherein the tablet is adapted to release more than 80% of the calcium carbonate within 5 minutes of mastication.
    Type: Application
    Filed: March 23, 2018
    Publication date: September 26, 2019
    Inventor: JESPER NEERGAARD
  • Publication number: 20190134207
    Abstract: The present invention relates to a nicotine delivery product comprising, or even consisting essentially of, a population of nicotine-loaded cation exchange resin particles, said population comprises at least 50% (w/w) particles having a size in the range of 90-300 micron which provides an improved nicotine stability to oral dosage forms comprising the nicotine delivery product. The invention furthermore relates to methods of producing the nicotine delivery product and the oral dosage forms and to the use of the nicotine delivery product.
    Type: Application
    Filed: April 21, 2016
    Publication date: May 9, 2019
    Applicant: Fertin Pharma A/S
    Inventors: Jesper Thorsen, Bjarne Vestbö, Birgitte Kringelum Breindal, Jesper Neergaard
  • Publication number: 20190060229
    Abstract: A medical chewing gum including gum base polymers and one or more cannabinoids as an active pharmaceutical ingredient, the gum base polymers including polyvinyl acetate and vinyl laurate-vinyl acetate copolymer in an amount of more than 90% by weight of the gum base polymers, wherein the gum base polymers include 20-95% by weight of polyvinyl acetate and 5-80% by weight of vinyl laurate-vinyl acetate copolymer.
    Type: Application
    Filed: October 7, 2015
    Publication date: February 28, 2019
    Inventors: Jesper Neergaard, Anayo Ogbonna